Navigation Links
ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
Date:6/20/2012

CONSHOHOCKEN, Pa., June 20, 2012 /PRNewswire/ -- ePharmaSolutions announces the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK.

ePharmaSolutions, a leading clinical services and technology solutions provider has acquired Polaris BioPharma Consulting to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies. This acquisition increases ePharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.

"We have worked closely with Polaris over the last ten years on some very complex projects, and they have always delivered," stated Lance Converse, ePharmaSolutions' Founder and CEO.   "They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrollment. This addition is integral to the company's continued growth."

Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.  Over the last 13 years, Polaris has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.

"We are proud to be a part of ePharmaSolutions and committed to our collective mission to improve and accelerate clinical trials through empirical expertise in patient recruitment, compliance and retention," stated Sanjiv Kanwar, Polaris Biopharma's Managing Director.   "We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide Sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns."

ePharmaSolutions and Polaris will be attending the Annual DIA Meeting in Philadelphia June 25th – 28th 2012 at booth 1427.

About ePharmaSolutions
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.  ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 260,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit www.epharmasolutions.com or email info@epharmasolutions.com

About Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm with over 20 regionally based recruitment specialists spanning each continent.   Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.  Polaris is headquartered in Slough, UK.   For more information visit www.polarisbpc.com or email info@polarisbpc.com


'/>"/>
SOURCE ePharmaSolutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
2. S.E.D. Labs to be Acquired by Quest Diagnostics
3. Celtaxsys Acquires Clinical Stage Innate Immunity Drug for Inflammation
4. TrovaGene Acquires CLIA - Certified Laboratory
5. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
8. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Amgen to Acquire Micromet
11. Camelot Healthcare Training Institute Acquired by Medtech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... Global Strategic Business Report" report to their offering. ... This report analyzes the ... Million. Annual estimates and forecasts are provided for the period 2014 ... secondary research. The report profiles 25 companies including ...
(Date:3/24/2017)... , March 24, 2017 Agenus Inc. ... immune checkpoint antibodies and cancer vaccines, today announced participation ... 7 th  Annual William Blair and Maidstone Life Sciences ... Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert B. ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... CT (PRWEB) , ... March 23, 2017 , ... ... LLC, was recently selected by the Connecticut Technology Council (CTC) as a 2017 ... at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes ...
Breaking Biology Technology:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):